YafiFABrimoFSteinbergJet al. Prospective analysis of sensitivity and specificity of urinary citology and other urinary biomarkers for bladder cancer. Urol Oncol2015;33:66.e25-31.
2.
LokeshwarVBHabuchiTGrossmanHBet al. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. Urology2005;66(6Suppl 1):35-63.
3.
BabjukMBöhleABurgerMet al. EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2016. Eur Urol2017;71:447-61.
4.
KołodziejAKrajewskiWMatuszewskiMTupikowskiK. Review of current optical diagnostic techniques for non-muscle-invasive bladder cancer. Cent European J Urol2016;69:150-6.
5.
DenzingerSBurgerMWalterBet al. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology2007;69:675-9.
6.
ChouRSelphSBuckleyDIet al. Comparative effectiveness of fluorescent versus white light cystoscopy for initial diagnosis or surveillance of bladder cancer on clinical outcomes: systematic review and meta-analysis. J Urol2017;197:548-58.
